search
Back to results

Silastic Stent Study

Primary Purpose

Pituitary Tumour

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Silastic Stent
Sponsored by
University of British Columbia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pituitary Tumour focused on measuring Silastic Stenting, Trans-nasal Endoscopic Surgery, Post-operative Intra-nasal Re-mucosalization

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients undergoing trans-sphenoidal endoscopic pituitary surgery at their first post-operative appointment

Exclusion Criteria:

  • patients with inflammatory sinus conditions
  • patients having undergone extensive skull base reconstructions
  • patients having received previous radiotherapy

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Silastic Stent

    No Stent

    Arm Description

    At the time of surgery, if the patient is identified in the "silastic stent" arm, dressing of the septal donor site with silastic stents will be performed after reconstruction has been achieved and the surgeon feels that the surgery proceeded routinely.

    At the time of surgery, if the patient is identified in the "no silastic stent" arm, dressing of the septal donor site without the stent will be performed after reconstruction has been achieved and the surgeon feels that the surgery proceeded routinely - this is currently the standard of care.

    Outcomes

    Primary Outcome Measures

    Determining the effect of silastic stunting on gross level healing of the naso-septal flap donor sites in two aspects gross level healing and microscopic level of healing.
    Visual assessment of endoscopic photographs of healing tissue.
    Determining the effect of silastic stunting on microscopic level healing of the naso-septal flap donor sites in two aspects gross level healing and microscopic level of healing.
    Histologic assessment of healing tissues.
    Determining the effect of silastic stunting on nasa-septal flap donor sites on the patient's subjective nasal symptoms following endoscopic skull based surgery.
    Participants will fill out a quality of life questionnaire called Sino-Nasal Outcome Test (SNOT-22).
    Determining the effect of silastic stunting on nasa-septal flap donor sites on the patient's subjective post-operative outcomes following endoscopic skull based surgery.
    Participants will fill out a post-operative rating scale.
    Physician's evaluation of the effect of silastic stunting on nasa-septal flap donor sites following endoscopic skull based surgery.
    Physician will fill out an outcome measures evaluation scale.

    Secondary Outcome Measures

    Full Information

    First Posted
    September 6, 2017
    Last Updated
    September 11, 2017
    Sponsor
    University of British Columbia
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03282058
    Brief Title
    Silastic Stent Study
    Official Title
    The Effect of Silastic Stenting on Post-Operative Intra-Nasal Re-Mucosalization
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    April 4, 2016 (Actual)
    Primary Completion Date
    December 31, 2018 (Anticipated)
    Study Completion Date
    December 31, 2018 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of British Columbia

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Endoscopic skull base surgery is a relatively new procedure that is now a standard of care for surgeries at the base of the skull; however there are no studies that examine the healing process of the nasal lining with the use of silastic (silicone) stents (or splints) that might be placed at the time of surgery. While there is some evidence to suggest that the use of stents improves wound healing, the decision to use a stent or not is currently up to the preference of the surgeon. To investigate the impact of stents on post-surgical healing, the investigators at Vancouver General Hospital will compare patients undergoing trans-sphenoidal pituitary surgeries with septal flap reconstruction with the use of silastic stents to line the septal donor site, and compare their recovery to those who did not receive stents. The investigators hypothesize that the use of silastic stents in endonasal surgery increases the rate of mucosal healing, and better quality mucosal regeneration, and with no effect on the patients experience after surgery. In this randomized control trial the investigators aim to recruit 26 (13 in each arm) study participants. The primary outcome is to determine the effect of silastic stunting on healing of the naso-septal flap donor site. This objective will be achieved by assessment of endoscopic photographs of healing tissue and histologic assessment of healing tissues. The secondary outcome involves questionnaires that measure the patient's subjective nasal symptoms prior to and following endoscopic skull based surgery. Total time commitment for the study participant is about 4 months across 4 study visits (all of which are part of standard of care): the assessment visit, surgery, 4 weeks post-operative follow up visit and 12 week post-operative follow up visit.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pituitary Tumour
    Keywords
    Silastic Stenting, Trans-nasal Endoscopic Surgery, Post-operative Intra-nasal Re-mucosalization

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Participants will be randomly assigned in one of two groups (stent vs no stent).
    Masking
    Outcomes Assessor
    Masking Description
    Histology of the healing tissues will be examined by a pathologist who is blinded to whether the patient received or did not receive stenting.
    Allocation
    Randomized
    Enrollment
    26 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Silastic Stent
    Arm Type
    Experimental
    Arm Description
    At the time of surgery, if the patient is identified in the "silastic stent" arm, dressing of the septal donor site with silastic stents will be performed after reconstruction has been achieved and the surgeon feels that the surgery proceeded routinely.
    Arm Title
    No Stent
    Arm Type
    No Intervention
    Arm Description
    At the time of surgery, if the patient is identified in the "no silastic stent" arm, dressing of the septal donor site without the stent will be performed after reconstruction has been achieved and the surgeon feels that the surgery proceeded routinely - this is currently the standard of care.
    Intervention Type
    Device
    Intervention Name(s)
    Silastic Stent
    Intervention Description
    The silastic stent is a splint made of silicone.
    Primary Outcome Measure Information:
    Title
    Determining the effect of silastic stunting on gross level healing of the naso-septal flap donor sites in two aspects gross level healing and microscopic level of healing.
    Description
    Visual assessment of endoscopic photographs of healing tissue.
    Time Frame
    Total time approx. 4 months (pre-operative assessment; surgery; 4 and 12 weeks post-operative follow up appointments)
    Title
    Determining the effect of silastic stunting on microscopic level healing of the naso-septal flap donor sites in two aspects gross level healing and microscopic level of healing.
    Description
    Histologic assessment of healing tissues.
    Time Frame
    Total time approx. 4 months (pre-operative assessment; surgery; 4 and 12 weeks post-operative follow up appointments)
    Title
    Determining the effect of silastic stunting on nasa-septal flap donor sites on the patient's subjective nasal symptoms following endoscopic skull based surgery.
    Description
    Participants will fill out a quality of life questionnaire called Sino-Nasal Outcome Test (SNOT-22).
    Time Frame
    Total time approx. 4 months (pre-operative assessment; surgery; 4 and 12 weeks post-operative follow up appointments)
    Title
    Determining the effect of silastic stunting on nasa-septal flap donor sites on the patient's subjective post-operative outcomes following endoscopic skull based surgery.
    Description
    Participants will fill out a post-operative rating scale.
    Time Frame
    Total time approx. 4 months (post-operative follow up at 4 and 12 weeks)
    Title
    Physician's evaluation of the effect of silastic stunting on nasa-septal flap donor sites following endoscopic skull based surgery.
    Description
    Physician will fill out an outcome measures evaluation scale.
    Time Frame
    Total time approx. 4 months (surgery; post-operative follow up at 4 and 12 weeks)

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: patients undergoing trans-sphenoidal endoscopic pituitary surgery at their first post-operative appointment Exclusion Criteria: patients with inflammatory sinus conditions patients having undergone extensive skull base reconstructions patients having received previous radiotherapy
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Arif Janjua, MD
    Organizational Affiliation
    University of British Columbia
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    19909864
    Citation
    Bednarski KA, Kuhn FA. Stents and drug-eluting stents. Otolaryngol Clin North Am. 2009 Oct;42(5):857-66, x. doi: 10.1016/j.otc.2009.07.001.
    Results Reference
    background
    Citation
    Cowin A, McIntosh D, Wormald PJ. Healing of wounds created in the nasal mucosa following endoscopic sinus surgery can be affected by different nasal packing materials. Primary Intention Vol. 10 No. 3 August 2002.
    Results Reference
    background
    PubMed Identifier
    3086802
    Citation
    Gamoletti R, Lanzarini P, Sanna M, Zini C. Regenerated middle ear mucosa after tympanoplasty. Part II. Scanning electron microscopy. Otolaryngol Head Neck Surg. 1986 Apr;94(4):430-4. doi: 10.1177/019459988609400404.
    Results Reference
    background
    PubMed Identifier
    1328786
    Citation
    Ng M, Linthicum FH Jr. Long-term effects of Silastic sheeting in the middle ear. Laryngoscope. 1992 Oct;102(10):1097-102. doi: 10.1288/00005537-199210000-00002.
    Results Reference
    background
    Citation
    Soper, D.S. (2014). A-priori Sample Size Calculator for Student t-Tests [Software]. Available from http://www.danielsoper.com/statcalc
    Results Reference
    background

    Learn more about this trial

    Silastic Stent Study

    We'll reach out to this number within 24 hrs